Work

Co-Administration of the mTORC1/TORC2 Inhibitor INK128 and the Bcl-2/Bcl-Xl Antagonist ABT-737 Kills Human Myeloid Leukemia Cells through Mcl-1 Down-Regulation and AKT Inactivation

Year: 2015

Type: article

Source: Blood

DOI: 10.1182/blood.v126.23.3676.3676

Authors: Mohamed Rahmani, Mandy Mayo Aust, Elisa Hawkins, Rebecca E Parker, Leonid Reshko, Masey Ross, Maciej Kmieciak, Kathryn Ann Rizzo, Catherine I Dumur, Andrea Ferreira-Gonzalez, Steven Grant

Institutions: VCU Massey Comprehensive Cancer Center, Virginia Commonwealth University

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2573438812

FWCI: 0.387

Cites:

Cited by: 4

Related to: 10